Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis
Obesity is common in patients with type 1 and type 2 diabetes. Amphetamine-like analogues comprise the most popular class of weight loss medications. We present a case of a 34-year-old African American female with a history of type 1 diabetes, dyslipidemia, and obesity who developed diabetic ketoaci...
Saved in:
| Main Authors: | Natalia M. Branis, Steven D. Wittlin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/917869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impaired ketogenesis in Leydig Cells drives testicular aging
by: Congyuan Liu, et al.
Published: (2025-05-01) -
Maladaptive Peripheral Ketogenesis in Schwann Cells Mediated by CB1R Contributes to Diabetic Neuropathy
by: Weizhen Li, et al.
Published: (2025-04-01) -
Amphetamines: a current epidemic
by: Norman Miller
Published: (2025-03-01) -
Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
by: Bin Wang, et al.
Published: (2022-12-01) -
Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism
by: Zhengzhong Luo, et al.
Published: (2025-12-01)